Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260325 · ClinicalTrials.gov registry record · Phase 4
Effect of Valdecoxib Pretreatment on Pain and Secondary Hyperalgesia in Healthy Volunteers
A Phase 4 study, sponsored by Penn State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00260325 is a Phase 4 study that has completed, run by Penn State University. The registered enrollment target is 20 participants.
The verdict
NCT00260325, a Phase 4 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Tis study was designed to test the hypothesis that pretreatment with valdecoxib, prior to injury could reduce or prevent the development of secondary hyperalgesia around the area of primary injury. A heat/capsaicin model of induced hyperalgesia was tested in healthy volunteers in a randomized, double blind, cross-over trial of a single dose of 40 mg vadecoxib versus control. Subjects rated pain intesnsity and unpleasantness following heat stimulation of the forearm, the area of hyperalgesia was also mapped over the course of the experiment.
Interventions
- DRUG valdecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260325
The ClinicalTrials.gov registry entry for NCT00260325 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which valdecoxib is the first listed.
NCT00260325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00260325 about?
NCT00260325 is a clinical study titled "Effect of Valdecoxib Pretreatment on Pain and Secondary Hyperalgesia in Healthy Volunteers". Tis study was designed to test the hypothesis that pretreatment with valdecoxib, prior to injury could reduce or prevent the development of secondary hyperalgesia around the area of primary injury. A heat/capsaicin model of induced hyperalgesia was tested in healthy volunteers in a randomized, doubl...
What is the current status of trial NCT00260325?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-08. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00260325?
The interventions under investigation include: valdecoxib (DRUG).
Who is sponsoring clinical trial NCT00260325?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.